Patent Assignment
Reel/Frame 061805/0076
Assignment of Assignor's Interest
Recorded: 2022-10-31
Pages: 27
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Properties
(30)
Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
Patent:
6,783,965 →
Application:
09/501,730 →
Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of Peg-Uricase
Purification of Proteins With Cationic Surfactant
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Form of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application:
15/165,318 →
Publication:
US 2016/0377604
Variant Forms of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Variant Forms of Urate Oxidase and Use Thereof
Purification of Proteins with Cationic Surfactant
Application:
16/455,073 →
Publication:
US 2020/0056160
Methods for Treating Gout
Reducing Immunogenicity to Pegloticase
Application:
16/777,646 →
Publication:
US 2020/0237881
Variant form of urate oxidase and use thereof
Application:
60/670,541 →
Reducing Immunogenicity to Pegloticase
Application:
62/855,519 →
Pegloticase for Treatment of Gout in Renal Transplant
Application:
62/894,452 →
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (Triple)
Application:
62/903,562 →
Reducing Immunogenicity to Pegloticase
Application:
62/903,567 →
Reducing Immunogenicity to Pegloticase
Application:
62/903,570 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 22, 2000
From: SHERMAN, MERRY R., PH.D.; SAIFER, MARK G.P., PH.D.; WILLIAMS, DAVID, PH.D.
To: MOUNTAIN VIEW PHARMACEUTICALS, INC.
Reel/Frame 010836/0572 →
Assignment of Assignor's Interest
May 24, 2006
From: HERSHFIELD, MICHAEL S.; KELLY, SUSAN J.
To: DUKE UNIVERSITY
Reel/Frame 017663/0313 →
Assignment of Assignor's Interest
Aug 28, 2007
From: REHRIG, CLAUDIA D.; HUANG, WILLIAM; HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 019756/0045 →
Assignment of Assignor's Interest
Jan 18, 2008
From: FISCHER, MEIR; HAROSH, ELIYAHU
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020383/0946 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020386/0145 →
Assignment of Assignor's Interest
Jan 18, 2008
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 020384/0974 →
Assignment of Assignor's Interest
Jul 23, 2008
From: HERSHFIELD, MICHAEL S.
To: DUKE UNIVERSITY
Reel/Frame 021278/0683 →
Security Agreement
Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Assignment of Assignor's Interest
Aug 3, 2012
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 028715/0585 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →
Security Agreement
Feb 21, 2014
From: CREALTA PHARMACEUTICALS LLC
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 032319/0077 →
Security Agreement
Mar 4, 2014
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 032384/0285 →
Assignment of Assignor's Interest
Apr 15, 2014
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, LLC
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 032675/0936 →
Security Interest
Jul 21, 2015
From: CREALTA PHARMACEUTICALS LLC
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 036142/0931 →
Assignment of Assignor's Interest
Aug 3, 2015
From: MOUNTAIN VIEW PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036240/0827 →
Security Interest
Aug 11, 2015
From: CREALTA PHARMACEUTICALS LLC
To: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
Reel/Frame 036300/0073 →
Assignment of Assignor's Interest
Aug 18, 2015
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 036388/0167 →
Release of Security Interest
Jan 13, 2016
From: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0073 →
Release of Security Interest
Jan 13, 2016
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0163 →
Release of Security Interest
Jan 13, 2016
From: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0148 →
Release of Security Interest
Jan 13, 2016
From: FIFTH STREET FINANCE CORP., AS COLLATERAL AGENT
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 037483/0049 →
Change of Name
Jul 5, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 039258/0154 →
Change of Name
Jul 5, 2016
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 039258/0152 →
Patent Security Agreement
Sep 16, 2016
From: HORIZON PHARMA RHEUMATOLOGY LLC (FORMERLY KNOWN AS CREALTA PHARMACEUTICALS LLC)
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040059/0007 →
Change of Name
Nov 18, 2016
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 040648/0361 →